Grand Rounds Nation: Recent Episodes
ReachMD
Grand Rounds, a staple of American medical education for more than 100 years, spans every field of clinical practice. It is a master class on the art and science of medicine, delivered by renowned clinicians in academic settings nationwide. Yet in today's practice, where time is an all-too precious commodity, regular attendance at Grand Rounds sessions has become increasingly difficult. In response to this challenge, ReachMD brings the lecture hall to you, with these outstanding talks from top academic centers across the country.
Discover how hearing loss in the US is growing and how it affects young and older people alike. Protect your patients' hearing with these tips and resources in an increasingly noisy world from Dr. John Iskander and Dr. William Murphy in this session of Beyond the Data.
Visit Dangerousdecibels.org to learn how to protect your hearing. Discover “How loud is too loud?”
In this session of Beyond the Data carrying forward ideas discussed at CDC's Public Health Grand Rounds, Dr. Phoebe Thorpe speaks with Dr. Bobbi Pritt, Director of the Clinical Parasitology Laboratory and Co-Director of Vector-borne Diseases Laboratory Services at the Mayo Clinic. The two expand on Dr. Pritt's lecture focusing on advances in diagnosing tickborne diseases.
In this session of Beyond the Data carrying forward ideas discussed at CDC's Public Health Grand Rounds, Dr. Phoebe Thorpe and Dr. Larry Garber expand on the reasons for medication non-adherence by patients, and priority considerations for helping reduce this risk.
Laboratory safety may sound straightforward, but in reality it is supported by complex and ever-changing science. Safety standards and practices evolve as scientists learn more about the materials they handle regularly.
In this session of Public Health Grand Rounds from the CDC, presenters will discuss how standards of laboratory safety have improved over the years, what we’ve learned from past incidents, and how establishing safety protocols and training systems can lead to an overall culture of workplace safety, resulting in continued public trust in our science and recommendations.
For more details on this Grand Rounds session and its participants, click here.
CDC's Dr. Phoebe Thorpe speaks with Dr. Sherif Zaki about the important work being done to further reduce the risk of unusual transplant-associated infections.
Ensuring that organs are safe requires:
- Involvement by many disciplines including: pathologists, epidemiologists, clinicians, and others
- Global collaboration between federal and state agencies as well as academic institutions
- Continued focus on improving regulations and screening procedures
CDC's Dr. John Iskander and Dr. Janet Wright discuss the progress that has been made with Million Hearts®, along with the work that is still needed to reach the goal of preventing one million heart attacks and strokes by 2017.
Providers should:
- Utilize electronic health records to proactively reach individuals with elevated blood pressure or cholesterol
- Place emphasis on detecting cases of uncontrolled high blood pressure which are hiding in plain sight
Communities can:
- Implement smoke-free policies to lower exposure to smoke
- Adopt food procurement policies that make healthier foods more readily available
- Encourage and train individuals to self-monitor their blood pressure
CDC's Dr. Phoebe Thorpe and Dr. David Lakey discuss the many costs of preterm birth, and how we can make prevention a priority in the United States. Tune in to find out how some states, like Texas, are educating the public and taking steps to reduce the rates of preterm birth and infant mortality.
Dr. John Iskander and Dr. George Luber revisit their discussion on climate change and its impact on human health to update some of the important new scientific findings that have taken place.
Since the first session on climate change:
- 2014 has been confirmed as the hottest year on record,
- Extreme climate events are occurring more frequently, and
- Communities are facing heightened health risks due to drought.
Global health security is the protection of the health of people and societies worldwide. With diseases a plane ride or border crossing away, the importance of global health security has never been clearer. Patterns of global travel and trade pose greater opportunities for infectious diseases to emerge and spread nearly anywhere within 24 hours. The Ebola epidemic in West Africa, which has infected more than 28,000 people across 10 countries and has caused more than 11,200 deaths, highlights the importance of ensuring that every country is prepared to prevent, detect, and respond to outbreaks and emerging health threats.
In this session of Public Health Grand Rounds from the CDC, experts discuss how CDC, other U.S. government agencies, and global partners are working to promote global health security as an international priority and accelerate progress toward a world safe and secure from epidemics of infectious disease.
For more details on this Grand Rounds session and its participants, click here.
Host: Matt Birnholz, MD
Twenty-five years ago CDC played a pivotal role in the discovery of the virus that causes hepatitis C. After the isolation of HCV, implementation of screening of blood products and organs for donation led to a decrease in rates of HCV infection between 1990 and 2009. In spite of these successes, HCV still remains a serious threat, both domestically and abroad. HCV remains the most common chronic blood borne infection in the United States, affecting approximately 3.9 million individuals. However up to 50% of HCV-infected persons are unaware of their infection. Globally, there are 180 million people who are chronically infected with the virus, and 3-4 million new infections occur every year.
Recent therapeutic advances hold the potential to halt the progression of HCV infection and disease. While HCV-infected persons can be effectively treated, more effort is needed to screen, diagnosis, treat and provide continuity of care. This session of Public Health Grand Rounds will discuss how new screening guidelines, testing methods and therapeutic advances will provide us with an opportunity to improve individual outcomes and to eventually eliminate HCV infection.
To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/
…
Host: Matt Birnholz, MD
Tuberculosis is an ancient disease that remains an important global cause of morbidity and mortality. In most cases, TB can be treated and cured by taking a combination of several drugs for 6 to 12 months. When inappropriate or incomplete treatment takes place, however, TB bacteria can develop multidrug resistance (MDR). Annually, there are approximately 500,000 cases of MDR TB, and 150,000 deaths. Although there are simple rapid tests that have improved the diagnosis of the disease, there is immense potential to increase the number of persons diagnosed with MDR TB, and to do so more quickly to initiate treatment sooner.
This session of CDC′s Public Health Grand Rounds will explore how more patients can benefit from advances in diagnostic and treatment options, resulting in an overall reduction in morbidity from MDR TB. The role of CDC, WHO and other partners in combating this public health epidemic will also be discussed.
To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/
Host: Matt Birnholz, MD
This session of Grand Rounds explores the burden of human papillomavirus (HPV) -associated cancer and disease in the United States and prevention through HPV vaccination. Each year, there are an estimated 26,000 HPV-attributable cancers in the United States. About 17,000 occur in women, most of which are cervical cancers, and about 9,000 occur in men, most of which are oropharyngeal cancers. CDC estimates that $8 billion are spent each year on direct medical costs for preventing and treating HPV-associated disease.
This session provides more insight about the HPV vaccination program and how CDC, state and local health departments, and health care providers are working together to achieve high vaccination levels and reduce the substantial burden of HPV-associated disease.
This is Part 3 of a lecture in three parts.
Part 1 >>
Part 2 >>
To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/
Host: Matt Birnholz, MD
This session of Grand Rounds explores the burden of human papillomavirus (HPV) -associated cancer and disease in the United States and prevention through HPV vaccination. Each year, there are an estimated 26,000 HPV-attributable cancers in the United States. About 17,000 occur in women, most of which are cervical cancers, and about 9,000 occur in men, most of which are oropharyngeal cancers. CDC estimates that $8 billion are spent each year on direct medical costs for preventing and treating HPV-associated disease.
This session provides more insight about the HPV vaccination program and how CDC, state and local health departments, and health care providers are working together to achieve high vaccination levels and reduce the substantial burden of HPV-associated disease.
This is Part 2 of a lecture in three parts.
Part 1 >>
Part 3 >>
To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/
Host: Matt Birnholz, MD
This session of Grand Rounds explores the burden of human papillomavirus (HPV) -associated cancer and disease in the United States and prevention through HPV vaccination. Each year, there are an estimated 26,000 HPV-attributable cancers in the United States. About 17,000 occur in women, most of which are cervical cancers, and about 9,000 occur in men, most of which are oropharyngeal cancers. CDC estimates that $8 billion are spent each year on direct medical costs for preventing and treating HPV-associated disease.
This session provides more insight about the HPV vaccination program and how CDC, state and local health departments, and health care providers are working together to achieve high vaccination levels and reduce the substantial burden of HPV-associated disease.
This is Part 1 of a lecture in three parts.
Part 2 >>
Part 3 >>
To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/
Host: Matt Birnholz, MD
This session of Grand Rounds Nation is provided by the American College of Osteopathic Family Physicians (ACOFP), and features Dr. Robert Hasty speaking on anticoagulation therapy guidelines for nonvalvular atrial fibrillation. Topics explored in depth include first vs second line drug regimens, updates on "golden windows" for initiating therapies, and effective risk stratification methods in practice.
Host: Matt Birnholz, MD
This session of Grand Rounds Nation is provided by the American College of Osteopathic Family Physicians (ACOFP), and features Dr. Robert Hasty speaking on anticoagulation therapy guidelines for nonvalvular atrial fibrillation. Topics explored in depth include first vs second line drug regimens, updates on "golden windows" for initiating therapies, and effective risk stratification methods in practice.
Host: Matt Birnholz, MD
This session of Grand Rounds Nation is provided by the American College of Osteopathic Family Physicians (ACOFP), and features Dr. Robert Hasty speaking on anticoagulation therapy guidelines for nonvalvular atrial fibrillation. Topics explored in depth include first vs second line drug regimens, updates on "golden windows" for initiating therapies, and effective risk stratification methods in practice.
Host: Matt Birnholz, MD
This session of Grand Rounds Nation is provided by the American College of Osteopathic Family Physicians (ACOFP), and features Dr. Richard Cottrell speaking on both first line and alternative approaches to the treatment of depression. Comparisons of antidepressive medications, counseling therapy models, and lifestyle modifications are explored. Additionally, novel treatment strategies in current use or on the horizon such as bright light therapy, transcranial magnetic stimulation, electroconvulsive therapy, and deep brain stimulation are investigated.
This is Part 2 of a lecture in two parts.
Part 1 >>
Host: Matt Birnholz, MD
This session of Grand Rounds Nation is provided by the American College of Osteopathic Family Physicians (ACOFP), and features Dr. Richard Cottrell speaking on both first line and alternative approaches to the treatment of depression. Comparisons of antidepressive medications, counseling therapy models, and lifestyle modifications are explored. Additionally, novel treatment strategies in current use or on the horizon such as bright light therapy, transcranial magnetic stimulation, electroconvulsive therapy, and deep brain stimulation are investigated.
This is Part 1 of a lecture in two parts.
Part 2 >>
Host: Matt Birnholz, MD
This session of Grand Rounds Nation is provided by the American College of Osteopathic Family Physicians (ACOFP), and features Dr. Anthony Brown, clinical assistant professor of medicine at the University of Medicine and Dentistry of New Jersey.
This is Part 3 of a lecture in three parts.
Part 1 >>
Part 2 >>
Host: Matt Birnholz, MD
This session of Grand Rounds Nation is provided by the American College of Osteopathic Family Physicians (ACOFP), and features Dr. Anthony Brown, clinical assistant professor of medicine at the University of Medicine and Dentistry of New Jersey.
This is Part 2 of a lecture in three parts.
Part 1 >>
Part 3 >>
Host: Matt Birnholz, MD
This session of Grand Rounds Nation is provided by the American College of Osteopathic Family Physicians (ACOFP), and features Dr. Anthony Brown, clinical assistant professor of medicine at the University of Medicine and Dentistry of New Jersey.
This is Part 1 of a lecture in three parts.
Part 2 >>
Part 3 >>
Host: Matt Birnholz, MD
This session of Grand Rounds Nation is provided by the American College of Osteopathic Family Physicians (ACOFP), and features Dr. Susan Zito, DO, MPH. Dr. Zito is a faculty physician at the Largo Medical Center in Largo, Florida.
This is Part 2 of a lecture in two parts.
Part 1 >>
Host: Matt Birnholz, MD
This session of Grand Rounds Nation is provided by the American College of Osteopathic Family Physicians (ACOFP), and features Dr. Susan Zito, DO, MPH. Dr. Zito is a faculty physician at the Largo Medical Center in Largo, Florida.
This is Part 1 of a lecture in two parts.
Part 2 >>
Host: Matt Birnholz, MD
This session of CDC′s Public Health Grand Rounds explores the control of tobacco use-the leading preventable cause of premature death and disease worldwide. Currently, approximately 6 million people die each year due to tobacco-related illnesses, a figure expected to increase to more than 8 million a year by 2030. If current global trends continue, tobacco use will cause up to 1 billion deaths in the 21st century.
Global tobacco control has been called a "best buy" in public health. Beyond monitoring of tobacco use and exposure, this session will discuss effective prevention strategies at the personal, population, and policy levels.
This is Part 2 of a lecture in two parts.
Part 1 >>
To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/
Host: Matt Birnholz, MD
This session of CDC′s Public Health Grand Rounds explores the control of tobacco use-the leading preventable cause of premature death and disease worldwide. Currently, approximately 6 million people die each year due to tobacco-related illnesses, a figure expected to increase to more than 8 million a year by 2030. If current global trends continue, tobacco use will cause up to 1 billion deaths in the 21st century.
Global tobacco control has been called a "best buy" in public health. Beyond monitoring of tobacco use and exposure, this session will discuss effective prevention strategies at the personal, population, and policy levels.
This is Part 1 of a lecture in two parts.
Part 2 >>
To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/
Host: Matt Birnholz, MD
This Presidential Plenary Scientific Session of the American College of Medical Genetics and Genomics (ACMG) is titled "The Coming Revolution in Medical Genetics: From Double Helix to Genomics and Back Again." Speaking is Dr. Wayne W. Grody, President of the ACMG and Professor in the Departments of Pathology & Laboratory Medicine, Pediatrics, and Human Genetics at the UCLA School of Medicine.
Host: Matt Birnholz, MD
This Prova Education program, presented by Deborah O'Connor PhD, RD, Professor of Pediatrics at the University of Toronto and Director of Clinical Dietetics at The Hospital for Sick Children, has been developed from the May 2011 live meeting in Denver, CO, A Month in the Life: Achieving Recommended Nutritional Status in Preterm, Low Birth Weight Infants Before, During and Beyond Hospital Discharge.
This program discusses preterm infant nutritional needs beginning at the NICU, the complexities of ensuring good nutritional status, and monitoring care through the transition to home and community settings. Through a review of new evidence-based information, physicians can apply practices that will support nutrition decisions for pre-term and low birth weight infants upon admittance to the NICU and continue through transitions.
Host: Matt Birnholz, MD
This Prova Education program, presented by Jae H. Kim, MD, PhD, Assistant Professor of Pediatrics at University of California, San Diego, has been developed from the May 2011 live meeting in Denver, CO, A Month in the Life: Achieving Recommended Nutritional Status in Preterm, Low Birth Weight Infants Before, During and Beyond Hospital Discharge.
This program discusses preterm infant nutritional needs beginning at the NICU, the complexities of ensuring good nutritional status, and monitoring care through the transition to home and community settings. Through a review of new evidence-based information, physicians can apply practices that will support nutrition decisions for pre-term and low birth weight infants upon admittance to the NICU and continue through transitions.
Host: Matt Birnholz, MD
National organizations such as the American Cancer Society and the American College of Obstetricians and Gynecology have published updated guidelines for cervical cancer screening. Crucial variations in these guidelines make implementing a sound, effective clinical protocol for management of gynecologic screening and treatment a challenge; and it is imperative that women's healthcare providers have a thorough understanding of clinical implications.
This Omnia Education program is presented by Dr. Thomas C. Wright, Jr., MD, Professor of Pathology at Columbia University College of Physicians and Surgeons.
Host: Matt Birnholz, MD
This Prova Education program, presented by Eyla G. Boies, MD, FAAP, FABM, Clinical Professor of Pediatrics at University of California, San Diego, has been developed from the May 2011 live meeting in Denver, CO, A Month in the Life: Achieving Recommended Nutritional Status in Preterm, Low Birth Weight Infants Before, During and Beyond Hospital Discharge.
This program discusses preterm infant nutritional needs beginning at the NICU, the complexities of ensuring good nutritional status, and monitoring care through the transition to home and community settings. Through a review of new evidence-based information, physicians can apply practices that will support nutrition decisions for pre-term and low birth weight infants upon admittance to the NICU and continue through transitions.
Host: Matt Birnholz, MD
This program will address the increasing prevalence of overweight, obese and type 2 diabetes conditions in our patient population. Physicians and healthcare professionals are confronted with multiple treatment and management challenges for type 2 diabetes. Treatment goals and care-delivery systems often present barriers to patients and clinician in achieving recommended therapeutic targets. These barriers will be identified along with suggested resources to assist in addressing these obstacles.
Presenting this Prova Education Activity is Dr. Brian McDonough, Clinical Professor of Family Medicine at Temple University School of Medicine and Chairman of the Department of Family Medicine at St. Francis Hospital.
This is Part 3 of a lecture in three parts.
Part 1 >>
Part 2 >>
To view the complete video recording of this and other Prova Education Activities, visit http://www.provaeducation.com
Host: Matt Birnholz, MD
This program will address the increasing prevalence of overweight, obese and type 2 diabetes conditions in our patient population. Physicians and healthcare professionals are confronted with multiple treatment and management challenges for type 2 diabetes. Treatment goals and care-delivery systems often present barriers to patients and clinician in achieving recommended therapeutic targets. These barriers will be identified along with suggested resources to assist in addressing these obstacles.
Presenting this Prova Education Activity is Dr. Brian McDonough, Clinical Professor of Family Medicine at Temple University School of Medicine and Chairman of the Department of Family Medicine at St. Francis Hospital.
This is Part 2 of a lecture in three parts.
Part 1 >>
Part 3 >>
To view the complete video recording of this and other Prova Education Activities, visit http://www.provaeducation.com
Host: Matt Birnholz, MD
This program will address the increasing prevalence of overweight, obese and type 2 diabetes conditions in our patient population. Physicians and healthcare professionals are confronted with multiple treatment and management challenges for type 2 diabetes. Treatment goals and care-delivery systems often present barriers to patients and clinician in achieving recommended therapeutic targets. These barriers will be identified along with suggested resources to assist in addressing these obstacles.
Presenting this Prova Education Activity is Dr. Brian McDonough, Clinical Professor of Family Medicine at Temple University School of Medicine and Chairman of the Department of Family Medicine at St. Francis Hospital.
This is Part 1 of a lecture in three parts.
Part 2 >>
Part 3 >>
To view the complete video recording of this and other Prova Education Activities, visit http://www.provaeducation.com
Host: Matt Birnholz, MD
Traumatic brain injury, or TBI, is a serious public health problem that affects approximately 1.7 million Americans every year. Of all injury deaths in our country, one in three cases are TBI-related, and an estimated 5.3 million Americans are living with a TBI-related disability. Beyond the potential for impairment to the cognitive, sensory, and motor functions in an individual, the economic burden of TBI is in excess of $76.5 billion. While significant advances in early treatment and prevention policies such as seat belt and motorcycle helmet laws have proven successful in reducing severe cases of TBI, many public health challenges remain. In addition to the economic impact of TBI, there is need for better surveillance, data, and coordination among the medical, public health and community sectors on both the civilian and military sides of the aisle.
This session of CDC′s Public Health Grand Rounds further addressed these challenges and explored promising policies, guidelines, and interventions such as progesterone treatments to further reduce the severity and number of cases of traumatic brain injury in the U.S.
This is Part 3 of a lecture in three parts.
Part 1 >>
Part 2 >>
To view the complete video recording of …
Host: Matt Birnholz, MD
Traumatic brain injury, or TBI, is a serious public health problem that affects approximately 1.7 million Americans every year. Of all injury deaths in our country, one in three cases are TBI-related, and an estimated 5.3 million Americans are living with a TBI-related disability. Beyond the potential for impairment to the cognitive, sensory, and motor functions in an individual, the economic burden of TBI is in excess of $76.5 billion. While significant advances in early treatment and prevention policies such as seat belt and motorcycle helmet laws have proven successful in reducing severe cases of TBI, many public health challenges remain. In addition to the economic impact of TBI, there is need for better surveillance, data, and coordination among the medical, public health and community sectors on both the civilian and military sides of the aisle.
This session of CDC′s Public Health Grand Rounds further addressed these challenges and explored promising policies, guidelines, and interventions such as progesterone treatments to further reduce the severity and number of cases of traumatic brain injury in the U.S.
This is Part 2 of a lecture in three parts.
Part 1 >>
Part 3 >>
To view the complete video recording of …
Host: Matt Birnholz, MD
Traumatic brain injury, or TBI, is a serious public health problem that affects approximately 1.7 million Americans every year. Of all injury deaths in our country, one in three cases are TBI-related, and an estimated 5.3 million Americans are living with a TBI-related disability. Beyond the potential for impairment to the cognitive, sensory, and motor functions in an individual, the economic burden of TBI is in excess of $76.5 billion. While significant advances in early treatment and prevention policies such as seat belt and motorcycle helmet laws have proven successful in reducing severe cases of TBI, many public health challenges remain. In addition to the economic impact of TBI, there is need for better surveillance, data, and coordination among the medical, public health and community sectors on both the civilian and military sides of the aisle.
This session of CDC′s Public Health Grand Rounds further addressed these challenges and explored promising policies, guidelines, and interventions such as progesterone treatments to further reduce the severity and number of cases of traumatic brain injury in the U.S.
This is Part 1 of a lecture in three parts.
Part 2 >>
Part 3 >>
To view the complete video recording of …
Host: Matt Birnholz, MD
Current Guidelines conclude that enlisting greater numbers of primary care clinicians to improve access to quality care will help people gain control of their asthma and allergy, thusly improving patients' quality of life. This activity was developed based on the current recommendations and guidelines issued by national organizations, and is designated to close gaps in knowledge, awareness, attitudes, and decision-making patterns related to the treatment and referral of patients with asthma and allergy.
Presenting this Prova Education Live Event is Dr. Michael Wechsler, Assistant Professor of Medicine at Harvard Medical School and Associate Director of the Brigham and Women's Hospital Asthma Research Center.
This is Part 2 of a lecture in two parts.
Part 1 >>
To view the complete video recording of this and other Prova Education Live Events, visit http://www.provaeducation.com
And to download a copy of the American Lung Association's "Asthma Action Plan" referenced in this program, visit http://www.lungusa.org/lung-disease/asthma/living-with-asthma/take-control-of-your-asthma/asthma-action-plan.html
Host: Matt Birnholz, MD
Current Guidelines conclude that enlisting greater numbers of primary care clinicians to improve access to quality care will help people gain control of their asthma and allergy, thusly improving patients' quality of life. This activity was developed based on the current recommendations and guidelines issued by national organizations, and is designated to close gaps in knowledge, awareness, attitudes, and decision-making patterns related to the treatment and referral of patients with asthma and allergy.
Presenting this Prova Education Live Event is Dr. Michael Wechsler, Assistant Professor of Medicine at Harvard Medical School and Associate Director of the Brigham and Women's Hospital Asthma Research Center.
This is Part 1 of a lecture in two parts.
Part 2 >>
To view the complete video recording of this and other Prova Education Live Events, visit http://www.provaeducation.com
And to download a copy of the American Lung Association's "Asthma Action Plan" referenced in this program, visit http://www.lungusa.org/lung-disease/asthma/living-with-asthma/take-control-of-your-asthma/asthma-action-plan.html
Host: Matt Birnholz, MD
Presenting this session of Grand Rounds is Dr. Gordon Ewy, professor and chief of cardiology at the University of Arizona College of Medicine.
To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.
Host: Matt Birnholz, MD
Presenting this session of Grand Rounds is Dr. Gordon Ewy, professor and chief of cardiology at the University of Arizona College of Medicine.
To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.
Host: Matt Birnholz, MD
Presenting this session of Grand Rounds is Dr. Gordon Ewy, professor and chief of cardiology at the University of Arizona College of Medicine.
To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.
Host: Matt Birnholz, MD
Beyond the inherent moral implications, child abuse is a crime, a tragedy, and a significant public health burden. In the United States, approximately 1 in 5 children have experienced some form of maltreatment, including physical and sexual abuse and the often overlooked danger of neglect. Child maltreatment results in over 1,700 deaths each year; however, the negative health effects reach well beyond these fatalities. In addition to physical injuries, maltreatment causes stress that can disrupt brain development. Thus, children who are maltreated are at higher risk for adult health problems such as alcoholism, smoking, depression, drug abuse, obesity, high-risk sexual behaviors, suicide, and certain chronic diseases.
This session of Public Health Grand Rounds from the CDC focused on the epidemiology and costs of child maltreatment, the need for partnerships, and the potential for policy interventions to combat this urgent public health issue.
This is Part 3 of a lecture in three parts.
Part 1 >>
Part 2 >>
To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/
And for those interested in receiving continuing education credits for the live broadcasts of Public Health Grand Rounds, register at http://www2a.cdc.gov/TCEOnline
CDC's …
Host: Matt Birnholz, MD
Beyond the inherent moral implications, child abuse is a crime, a tragedy, and a significant public health burden. In the United States, approximately 1 in 5 children have experienced some form of maltreatment, including physical and sexual abuse and the often overlooked danger of neglect. Child maltreatment results in over 1,700 deaths each year; however, the negative health effects reach well beyond these fatalities. In addition to physical injuries, maltreatment causes stress that can disrupt brain development. Thus, children who are maltreated are at higher risk for adult health problems such as alcoholism, smoking, depression, drug abuse, obesity, high-risk sexual behaviors, suicide, and certain chronic diseases.
This session of Public Health Grand Rounds from the CDC focused on the epidemiology and costs of child maltreatment, the need for partnerships, and the potential for policy interventions to combat this urgent public health issue.
This is Part 2 of a lecture in three parts.
Part 1 >>
Part 3 >>
To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/
And for those interested in receiving continuing education credits for the live broadcasts of Public Health Grand Rounds, register at http://www2a.cdc.gov/TCEOnline
CDC's …
Host: Matt Birnholz, MD
Beyond the inherent moral implications, child abuse is a crime, a tragedy, and a significant public health burden. In the United States, approximately 1 in 5 children have experienced some form of maltreatment, including physical and sexual abuse and the often overlooked danger of neglect. Child maltreatment results in over 1,700 deaths each year; however, the negative health effects reach well beyond these fatalities. In addition to physical injuries, maltreatment causes stress that can disrupt brain development. Thus, children who are maltreated are at higher risk for adult health problems such as alcoholism, smoking, depression, drug abuse, obesity, high-risk sexual behaviors, suicide, and certain chronic diseases.
This session of Public Health Grand Rounds from the CDC focused on the epidemiology and costs of child maltreatment, the need for partnerships, and the potential for policy interventions to combat this urgent public health issue.
This is Part 1 of a lecture in three parts.
Part 2 >>
Part 3 >>
To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/
And for those interested in receiving continuing education credits for the live broadcasts of Public Health Grand Rounds, register at http://www2a.cdc.gov/TCEOnline
CDC's …
Host: Matt Birnholz, MD
Presenting this session of Grand Rounds is Dr. Leslie Boyer, founding director of the VIPER Institute in the College of Medicine at the University of Arizona.
This is Part 3 of a lecture in three parts.
Part 1 >>
Part 2 >>
To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.
Host: Matt Birnholz, MD
Presenting this session of Grand Rounds is Dr. Leslie Boyer, founding director of the VIPER Institute in the College of Medicine at the University of Arizona.
This is Part 2 of a lecture in three parts.
Part 1 >>
Part 3 >>
To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.
Host: Matt Birnholz, MD
Presenting this session of Grand Rounds is Dr. Leslie Boyer, founding director of the VIPER Institute in the College of Medicine at the University of Arizona.
This is Part 1 of a lecture in three parts.
Part 2 >>
Part 3 >>
To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.
Host: Matt Birnholz, MD
Lyme disease is one of the most rapidly emerging infectious diseases in North America and Europe. In 2009, nearly 30,000 confirmed and more than 8,500 probable cases of Lyme disease were reported to the CDC in the United States alone. Named after a small Connecticut town, Lyme disease is transmitted to humans by the bite of ticks infected with the bacterium Borrelia burgdorferi. This multi-system infection typically occurs in stages with different clinical manifestations at each stage. While it can be treated effectively with antibiotics, in some cases recovery may be incomplete - although there is no evidence that any of these post-Lyme disease syndromes respond to further courses of antibiotic therapy.
Dr. Allen Steere, the renowned discoverer of Lyme disease, joins an esteemed panel of speakers for CDC's Public Health Grand Rounds to explore the clinical manifestations and treatment of Lyme disease, innovations in laboratory testing, prevention strategies, and national trends of disease emergence. The session gives a rare glimpse into the front lines of those battling and treating Lyme disease while addressing the data gaps, unmet needs, and overall challenges and opportunities for its prevention and control.
This is Part 3 of a lecture in three parts.
Host: Matt Birnholz, MD
Lyme disease is one of the most rapidly emerging infectious diseases in North America and Europe. In 2009, nearly 30,000 confirmed and more than 8,500 probable cases of Lyme disease were reported to the CDC in the United States alone. Named after a small Connecticut town, Lyme disease is transmitted to humans by the bite of ticks infected with the bacterium Borrelia burgdorferi. This multi-system infection typically occurs in stages with different clinical manifestations at each stage. While it can be treated effectively with antibiotics, in some cases recovery may be incomplete - although there is no evidence that any of these post-Lyme disease syndromes respond to further courses of antibiotic therapy.
Dr. Allen Steere, the renowned discoverer of Lyme disease, joins an esteemed panel of speakers for CDC's Public Health Grand Rounds to explore the clinical manifestations and treatment of Lyme disease, innovations in laboratory testing, prevention strategies, and national trends of disease emergence. The session gives a rare glimpse into the front lines of those battling and treating Lyme disease while addressing the data gaps, unmet needs, and overall challenges and opportunities for its prevention and control.
This is Part 2 of a lecture in three parts.
Host: Matt Birnholz, MD
Lyme disease is one of the most rapidly emerging infectious diseases in North America and Europe. In 2009, nearly 30,000 confirmed and more than 8,500 probable cases of Lyme disease were reported to the CDC in the United States alone. Named after a small Connecticut town, Lyme disease is transmitted to humans by the bite of ticks infected with the bacterium Borrelia burgdorferi. This multi-system infection typically occurs in stages with different clinical manifestations at each stage. While it can be treated effectively with antibiotics, in some cases recovery may be incomplete - although there is no evidence that any of these post-Lyme disease syndromes respond to further courses of antibiotic therapy.
Dr. Allen Steere, the renowned discoverer of Lyme disease, joins an esteemed panel of speakers for CDC's Public Health Grand Rounds to explore the clinical manifestations and treatment of Lyme disease, innovations in laboratory testing, prevention strategies, and national trends of disease emergence. The session gives a rare glimpse into the front lines of those battling and treating Lyme disease while addressing the data gaps, unmet needs, and overall challenges and opportunities for its prevention and control.
This is Part 1 of a lecture in three parts.
Host: Matt Birnholz, MD
Presenting this session of Grand Rounds is Dr. Mark J. Friedman, clinical professor of medicine and director of the Heart Failure Program at the University of Arizona.
This is Part 3 of a lecture in three parts.
Part 1 >>
Part 2 >>
To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.
Host: Matt Birnholz, MD
This is Part 2 of a lecture in three parts.
Part 1 >>
Part 3 >>
To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.
Host: Matt Birnholz, MD
Presenting this session of Grand Rounds is Dr. Mark J. Friedman, clinical professor of medicine and director of the Heart Failure Program at the University of Arizona.
This is Part 1 of a lecture in three parts.
Part 2 >>
Part 3 >>
To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.
Host: Matt Birnholz, MD
The vast majority of US adults consume more than double the recommended maximum of sodium, which is a direct cause of hypertension, a condition that affects nearly 1 in 3 Americans. Hypertension is not only a major contributor to cardiovascular disease (CVD), disability, and health disparities, but the treatment of related CVDs can cost our already overburdened health system $273 billion annually.
Sadly, the public does not always have a choice when it comes to reducing sodium intake: we cannot remedy this problem simply by removing the salt shaker from our tables. Of the 3,400 mg of sodium the average American consumes daily, nearly 80% is invisible in sources such as restaurant and processed foods. And once the salt is in the food, it cannot be taken out!
This session of Public Health Grand Rounds explored the consequences of excessive sodium intake and discussed the technological context for the use of salt in our food supply. The speakers reviewed current sodium control efforts, such as the National Salt Reduction Initiative and food procurement policies, and separated fact from fiction to support actions needed to address this very real public health burden.
This is Part 3 of a lecture in three …
Host: Matt Birnholz, MD
The vast majority of US adults consume more than double the recommended maximum of sodium, which is a direct cause of hypertension, a condition that affects nearly 1 in 3 Americans. Hypertension is not only a major contributor to cardiovascular disease (CVD), disability, and health disparities, but the treatment of related CVDs can cost our already overburdened health system $273 billion annually.
Sadly, the public does not always have a choice when it comes to reducing sodium intake: we cannot remedy this problem simply by removing the salt shaker from our tables. Of the 3,400 mg of sodium the average American consumes daily, nearly 80% is invisible in sources such as restaurant and processed foods. And once the salt is in the food, it cannot be taken out!
This session of Public Health Grand Rounds explored the consequences of excessive sodium intake and discussed the technological context for the use of salt in our food supply. The speakers reviewed current sodium control efforts, such as the National Salt Reduction Initiative and food procurement policies, and separated fact from fiction to support actions needed to address this very real public health burden.
This is Part 2 of a lecture in three …
Host: Matt Birnholz, MD
The vast majority of US adults consume more than double the recommended maximum of sodium, which is a direct cause of hypertension, a condition that affects nearly 1 in 3 Americans. Hypertension is not only a major contributor to cardiovascular disease (CVD), disability, and health disparities, but the treatment of related CVDs can cost our already overburdened health system $273 billion annually.
Sadly, the public does not always have a choice when it comes to reducing sodium intake: we cannot remedy this problem simply by removing the salt shaker from our tables. Of the 3,400 mg of sodium the average American consumes daily, nearly 80% is invisible in sources such as restaurant and processed foods. And once the salt is in the food, it cannot be taken out!
This session of Public Health Grand Rounds from the CDC explored the consequences of excessive sodium intake and discussed the technological context for the use of salt in our food supply. The speakers reviewed current sodium control efforts, such as the National Salt Reduction Initiative and food procurement policies, and separated fact from fiction to support actions needed to address this very real public health burden.
This is Part 1 of a …
Host: Matt Birnholz, MD
For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss.
In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from an unique perspective of the preclinical stage. From classical signs on physicial exam to emerging biomolecular lab tests and novel imaging modalities, the pathophysiologic changes underlying Alzheimer's Disease are explored in depth.
Presenting this session of Grand Rounds is Dr. Richard Caselli, behavioral neurologist and professor of neurology at the Mayo Clnic in Scottsdale, Arizona.
This is Part 3 of a lecture in three parts.
Part 1 >>
Part 2 >>
To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.
Host: Matt Birnholz, MD
For people who carry genetic predispositions toward Alzheimer's Disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss.
In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from an unique perspective of the preclinical stage. From classical signs on physicial exam to emerging biomolecular lab tests and novel imaging modalities, the pathophysiologic changes underlying Alzheimer's Disease are explored in depth.
Presenting this session of Grand Rounds is Dr. Richard Caselli, behavioral neurologist and professor of neurology at the Mayo Clnic in Scottsdale, Arizona.
This is Part 2 of a lecture in three parts.
Part 1 >>
Part 3 >>
To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.
Host: Matt Birnholz, MD
For people who carry genetic predispositions toward Alzheimer's disease, little is currently known about predicting the onset, course, and severity of disease at the individual level. However, because cogntitive degenerative diseases most often follow a gradual course of symptom progression later in life, medical professionals must be aware of the distinct, discoverable changes that occur at the "preclinical" stage, i.e prior to the symptomatic onset of memory loss.
In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about Alzheimer's Disease from a unique perspective of the preclinical stage. From classical signs on physicial exam to emerging biomolecular lab tests and novel imaging modalities, the pathophysiologic changes underlying Alzheimer's disease are explored in depth.
Presenting this session of Grand Rounds is Dr. Richard Caselli, behavioral neurologist and professor of neurology at the Mayo Clnic in Scottsdale, Arizona.
This is Part 1 of a lecture in three parts.
Part 2 >>
Part 3 >>
To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.
Host: Matt Birnholz, MD
The CDC commemorates Dr. Robert Koch's 1882 discovery of Mycobacterium tuberculosis, the bacteria that causes TB. Over the past 129 years, history has witnessed many advances over in TB control. Through the intervention efforts of CDC, USAID, WHO's Stop TB Partnership, and many others, TB death rates have fallen by 35% since 1990, and as many as 6 million lives have been saved since 1995.
In spite of these successes, TB still remains a serious threat, especially for those infected with HIV. HIV is the single most powerful risk factor for TB disease and one of the leading causes of death among people infected with HIV. Among the 1.7 million lives that TB claimed in 2009, 380,000 were among people with HIV infection. While people with HIV who have TB can be effectively diagnosed and treated, more effort is needed to diagnose and treat TB promptly and effectively, and to scale-up preventive treatment for TB.
This special session of Public Health Grand Rounds shed light on myths and misconceptions about TB and HIV, and discussed actions needed in preventing deaths from this lethal combination.
This is Part 3 of a lecture in three parts.
Part 1 >>
Part …
Host: Matt Birnholz, MD
The CDC commemorates Dr. Robert Koch's 1882 discovery of Mycobacterium tuberculosis, the bacteria that causes TB. Over the past 129 years, history has witnessed many advances over in TB control. Through the intervention efforts of CDC, USAID, WHO's Stop TB Partnership, and many others, TB death rates have fallen by 35% since 1990, and as many as 6 million lives have been saved since 1995.
But in spite of these successes, TB still remains a serious threat, especially for those infected with HIV— the single most powerful risk factor for TB disease and one of the leading causes of death among people infected with HIV. Among the 1.7 million lives that TB claimed in 2009, 380,000 were among people with HIV infection. While people with HIV who have TB can be effectively diagnosed and treated, more effort is needed to diagnose and treat TB promptly and effectively, and to scale-up preventive treatment for TB.
This special session of Public Health Grand Rounds sheds light on myths and misconceptions about TB and HIV, and discusses actions needed in preventing deaths from this lethal combination.
This is Part 2 of a lecture in three parts.
Part 1 >>
Part …
Host: Matt Birnholz, MD
The CDC commemorates Dr. Robert Koch's 1882 discovery of Mycobacterium tuberculosis, the bacteria that causes TB. Over the past 129 years, history has witnessed many advances over in TB control. Through the intervention efforts of CDC, USAID, WHO's Stop TB Partnership, and many others, TB death rates have fallen by 35% since 1990, and as many as 6 million lives have been saved since 1995.
In spite of these successes, TB still remains a serious threat, especially for those infected with HIV. HIV is the single most powerful risk factor for TB disease and one of the leading causes of death among people infected with HIV. Among the 1.7 million lives that TB claimed in 2009, 380,000 were among people with HIV infection. While people with HIV who have TB can be effectively diagnosed and treated, more effort is needed to diagnose and treat TB promptly and effectively, and to scale-up preventive treatment for TB.
This special session of Public Health Grand Rounds shed light on myths and misconceptions about TB and HIV, and discussed actions needed in preventing deaths from this lethal combination.
This is Part 1 of a lecture in three parts.
Part 2 >>
Part …
Host: Matt Birnholz, MD
Recognizing the respiratory manifestations of neuromuscular disease in children is a critical first step toward protecting their survival and improving their quality of life. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about the art of assessing respiratory problems in these children, and the treatment options available for optimizing long-term management.
Presenting this session of Grand Rounds is Dr. Cori Daines, pediatric pulmonologist and associate professor of pediatrics at the University of Arizona College of Medicine. Dr. Daines is director of the pediatric bronchoscopy program, and co-director of the Tuscon Cystic Fibrosis Center.
This is Part 3 of a lecture in three parts.
Part 1 >>
Part 2 >>
To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.
Host: Matt Birnholz, MD
Recognizing the respiratory manifestations of neuromuscular disease in children is a critical first step toward protecting their survival and improving their quality of life. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about the art of assessing respiratory problems in these children, and the treatment options available for optimizing long-term management.
Presenting this session of Grand Rounds is Dr. Cori Daines, pediatric pulmonologist and associate professor of pediatrics at the University of Arizona College of Medicine. Dr. Daines is director of the pediatric bronchoscopy program, and co-director of the Tuscon Cystic Fibrosis Center.
This is Part 2 of a lecture in three parts.
Part 1 >>
Part 3 >>
To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.
Host: Matt Birnholz, MD
Recognizing the respiratory manifestations of neuromuscular disease in children is a critical first step toward protecting their survival and improving their quality of life. In this session of Grand Rounds from the University of Arizona College of Medicine, participants learn about the art of assessing respiratory problems in these children, and the treatment options available for optimizing long-term management.
Presenting this session of Grand Rounds is Dr. Cori Daines, pediatric pulmonologist and associate professor of pediatrics at the University of Arizona College of Medicine. Dr. Daines is director of the pediatric bronchoscopy program, and co-director of the Tuscon Cystic Fibrosis Center.
This is Part 1 of a lecture in three parts.
Part 2 >>
Part 3 >>
To view the complete video recording of this and other Grand Rounds sessions from the University of Arizona College of Medicine, visit their website.
Host: Matt Birnholz, MD
The United States is in the grip of an epidemic of prescription drug overdoses. Over 27,000 people died from overdoses in 2007, a number that has risen five-fold since 1990 and has never been higher. Prescription drugs are now involved in more overdose deaths than heroin and cocaine combined.
For health professionals, policymakers and legislators, addressing this problem is complicated. While they push for education, prevention, and enforcement to reverse this epidemic, they must also ensure that patients with a legitimate need for these medications still have access to them. This important session of the CDC's Public Health Grand Rounds addressed these challenges and explored the innovative state and federal policies and interventions that are showing promise in reducing injury and death from this epidemic.
This is Part 3 of a 45-minute lecture in three parts.
Part 1 >>
Part 2 >>
To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/.
And for those interested in receiving continuing education credits for the live broadcasts of Public Health Grand Rounds, register at http://www2a.cdc.gov/TCEOnline.
CDC's participation in the activity is not meant to serve as …
Host: Matt Birnholz, MD
The United States is in the grip of an epidemic of prescription drug overdoses. Over 27,000 people died from overdoses in 2007, a number that has risen five-fold since 1990 and has never been higher. Prescription drugs are now involved in more overdose deaths than heroin and cocaine combined.
For health professionals, policymakers and legislators, addressing this problem is complicated. While they push for education, prevention, and enforcement to reverse this epidemic, they must also ensure that patients with a legitimate need for these medications still have access to them. This important session of the CDC's Public Health Grand Rounds addressed these challenges and explored the innovative state and federal policies and interventions that are showing promise in reducing injury and death from this epidemic.
This is Part 2 of a 45-minute lecture in three parts.
Part 1 >>
Part 3 >>
To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/
And for those interested in receiving continuing education credits for the live broadcasts of Public Health Grand Rounds, register at http://www2a.cdc.gov/TCEOnline.
CDC's participation in the activity is not meant to serve as an …
Host: Matt Birnholz, MD
The United States is in the grip of an epidemic of prescription drug overdoses. Over 27,000 people died from overdoses in 2007, a number that has risen five-fold since 1990 and has never been higher. Prescription drugs are now involved in more overdose deaths than heroin and cocaine combined.
For health professionals, policymakers and legislators, addressing this problem is complicated. While they push for education, prevention, and enforcement to reverse this epidemic, they must also ensure that patients with a legitimate need for these medications still have access to them. This important session of the CDC's Public Health Grand Rounds addressed these challenges and explored the innovative state and federal policies and interventions that are showing promise in reducing injury and death from this epidemic.
This is Part 1 of a lecture in three parts.
Part 2 >>
Part 3 >>
To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/
And for those interested in receiving continuing education credits for the live broadcasts of Public Health Grand Rounds, register at http://www2a.cdc.gov/TCEOnline.
CDC's participation in the activity is not meant to serve as an …